Clinical Trials Browser

Pediatric Solid Tumors × Irinotecan × Clear all

NCT02747537 2019-09-09

Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors With Sorafenib in Combination With Irinotecan

Phase 2 Withdrawn

Other solid neoplasm

Pediatric Solid Tumors

NCT00990912 2010-02-05

A Study to Document Long-Term Safety and Continued Benefit of Irinotecan and Carboplatin or Irinotecan in Subjects With Refractory Solid Tumors (Rollover Study -001, -002)

Phase 1/2 Completed

Other solid neoplasm

Pediatric Solid Tumors